Search results for "133"

showing 10 items of 144 documents

miR-133a Enhances the Protective Capacity of Cardiac Progenitors Cells after Myocardial Infarction

2014

Summary miR-133a and miR-1 are known as muscle-specific microRNAs that are involved in cardiac development and pathophysiology. We have shown that both miR-1 and miR-133a are early and progressively upregulated during in vitro cardiac differentiation of adult cardiac progenitor cells (CPCs), but only miR-133a expression was enhanced under in vitro oxidative stress. miR-1 was demonstrated to favor differentiation of CPCs, whereas miR-133a overexpression protected CPCs against cell death, targeting, among others, the proapoptotic genes Bim and Bmf. miR-133a-CPCs clearly improved cardiac function in a rat myocardial infarction model by reducing fibrosis and hypertrophy and increasing vasculari…

Cardiac function curveProgrammed cell deathMyocardial InfarctionGene ExpressionCardiomegalyBiologyBiochemistryArticleMuscle hypertrophyParacrine signallingDownregulation and upregulationmiR-133a; Cardiac Progenitors Cells; Myocardial InfarctionFibrosisREGENERATIONmicroRNAGeneticsmedicineMyocyteAnimalsRNA MessengerOXIDATIVE STRESSlcsh:QH301-705.5ENGINEERED HEART-TISSUElcsh:R5-920Gene Expression ProfilingMICRORNAComputational BiologyCell BiologyMUSCLEmedicine.disease3. Good healthCell biologyRatsAPOPTOSISHYPERTROPHYMicroRNAsDIFFERENTIATIONlcsh:Biology (General)ImmunologyGROWTHRNA Interferencelcsh:Medicine (General)EMBRYONIC STEM-CELLSMyoblasts CardiacDevelopmental BiologyStem Cell Reports
researchProduct

Therapeutic implications of Cancer Initiating Cells.

2009

Background: Until few years ago, all neoplastic cells within a tumour were suggested to have tumorigenic capacity, but recent evidences hint to the possibility that such feature is confined to a subset of Cancer Initiating Cells (CICs), also called Cancer Stem Cells (CSCs). These cells are the reservoir of the heterogeneous populations of differentiated cancer cells constituting the tumour bulk. Mechanisms shared with somatic stem cells, such as quiescence, self-renewal ability, asymmetric division and multidrug resistance, allow to these cells to drive tumour growth and to evade conventional therapy. Objective: Here, we give a brief overview on the origin of CICs, the mechanisms involved i…

Clinical BiochemistryCellPopulationCell- and Tissue-Based TherapyApoptosisBiologymedicine.disease_causeMedical OncologyDisease-Free SurvivalMiceCancer stem cellAntigens CDNeoplasmsDrug DiscoverymedicineAnimalsHumansAC133 AntigenNeoplasm MetastasiseducationInterleukin 4GlycoproteinsPharmacologyeducation.field_of_studyCancermedicine.diseasemedicine.anatomical_structureCell Transformation NeoplasticDrug Resistance NeoplasmImmunologyCancer cellCancer researchNeoplastic Stem Cellscancer initiating cells cancer stem cells drug resistance IL-4CarcinogenesisPeptidesNeoplasm TransplantationAdult stem cellExpert opinion on biological therapy
researchProduct

Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells.

2012

Abstract Tumor-initiating cells are responsible for tumor maintenance and relapse in solid and hematologic cancers. Although tumor-initiating cells were initially believed to be mainly quiescent, rapidly proliferating tumorigenic cells were found in breast cancer. In colon cancer, the proliferative activity of the tumorigenic population has not been defined, although it represents an essential parameter for the development of more effective therapeutic strategies. Here, we show that tumorigenic colon cancer cells can be found in a rapidly proliferating state in vitro and in vivo, both in human tumors and mouse xenografts. Inhibitors of polo-like kinase1 (Plk1), a mitotic kinase essential fo…

Colorectal cancerCancer stem cellscolorectal cancercell proliferationcell cycle.Cell Cycle ProteinsMice0302 clinical medicineMice Inbred NODAC133 AntigenRNA Small Interfering0303 health scienceseducation.field_of_studyPteridinesCell CycleCell cycleImmunohistochemistry3. Good healthMitochondriaGene Expression Regulation Neoplastic030220 oncology & carcinogenesisColonic NeoplasmsMolecular MedicineFemaleStem cellPopulationTransplantation HeterologousCell Growth ProcessesBiologyProtein Serine-Threonine KinasesPLK103 medical and health sciencesCancer stem cellAntigens CDCell Line TumorProto-Oncogene ProteinsmedicineAnimalsHumanseducationProtein Kinase Inhibitors030304 developmental biologyGlycoproteinsSettore MED/04 - Patologia GeneraleCell growthCell Biologymedicine.diseaseTumor progressionImmunologyCancer researchPeptidesDevelopmental BiologyStem cells (Dayton, Ohio)
researchProduct

"Table 24" of "Measurement of event shape and inclusive distributions at s**(1/2) = 130-GeV and 136-GeV."

1997

3-jet rate for the Jade Algorithm.

Computer Science::Multiagent Systems133.0E+ E- --> 3JETAstrophysics::High Energy Astrophysical PhenomenaE+ E- ScatteringIntegrated Cross SectionExclusiveHigh Energy Physics::ExperimentJet ProductionCross SectionSIGComputer Science::Distributed Parallel and Cluster Computing
researchProduct

"Table 23" of "Measurement of event shape and inclusive distributions at s**(1/2) = 130-GeV and 136-GeV."

1997

2-jet rate for the Jade Algorithm.

Computer Science::Multiagent SystemsDijet Production133.0Astrophysics::High Energy Astrophysical PhenomenaE+ E- ScatteringIntegrated Cross SectionExclusiveHigh Energy Physics::ExperimentJet ProductionE+ E- --> 2JETCross SectionSIGComputer Science::Distributed Parallel and Cluster Computing
researchProduct

"Table 25" of "Measurement of event shape and inclusive distributions at s**(1/2) = 130-GeV and 136-GeV."

1997

4-jet rate for the Jade Algorithm.

Computer Science::Multiagent SystemsE+ E- --> 4JET133.0Astrophysics::High Energy Astrophysical PhenomenaE+ E- ScatteringIntegrated Cross SectionExclusiveHigh Energy Physics::ExperimentJet ProductionCross SectionSIGComputer Science::Distributed Parallel and Cluster Computing
researchProduct

"Table 26" of "Measurement of event shape and inclusive distributions at s**(1/2) = 130-GeV and 136-GeV."

1997

5-jet rate for the Jade Algorithm.

Computer Science::Multiagent SystemsE+ E- --> 5JET133.0Astrophysics::High Energy Astrophysical PhenomenaE+ E- ScatteringIntegrated Cross SectionExclusiveHigh Energy Physics::ExperimentJet ProductionCross SectionSIGComputer Science::Distributed Parallel and Cluster Computing
researchProduct

"Table 14" of "Measurement of event shape and inclusive distributions at s**(1/2) = 130-GeV and 136-GeV."

1997

Oblateness distribution. Axis definition is from corrected charged plus neutral particles.

Condensed Matter::Quantum GasesInclusiveDN/DOBLATENESS133.0E+ E- --> NEUTRAL XE+ E- ScatteringPhysics::Space PhysicsPhysics::Atomic and Molecular ClustersE+ E- --> CHARGED XSingle Differential Distribution
researchProduct

"Table 134" of "Studies of QCD at e+ e- centre-of-mass energies between 91-GeV and 209-GeV."

2004

Oblateness distribution at c.m. energy 133.00 GeV.

Condensed Matter::Quantum GasesSingle Differential Cross Section133.0DSIG/DOBLATENESSE+ E- --> HADRONSE+ E- ScatteringPhysics::Space PhysicsPhysics::Atomic and Molecular ClustersExclusiveHigh Energy Physics::ExperimentNuclear Experiment
researchProduct

"Table 25" of "Energy dependence of event shapes and of alpha(s) at LEP-2."

1999

Distributions of Aplanarity at cm energies 133, 161 and 172 GeV.

DN/DAPLANARITYE+ E- --> HADRONSE+ E- --> JETSE+ E- ScatteringExclusiveSingle Differential DistributionJet Production133.0-172.0
researchProduct